| Product Information |
|
| Registration Number |
BR-955
|
| Generic Name |
Varicella Virus Vaccine, Live
|
| Brand Name |
Varivax
|
| Dosage Strength |
1350 PFU/0.5 mL
|
| Dosage Form |
Lyophilized Powder For Solution
for Injection (SC)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
Vaccine
|
| Packaging |
Vaccine in Borosilicate USP/ Ph Eur Type I glass vial w/ butyl chlorobutyl stopper, capped w/ aluminum seal & plastic cap w/ sterile diluent in a separate vial (Box of 1's or 10's)
|
| Manufacturer |
Merck Sharp & Dohme Corp.
|
| Country of Origin |
United States of America
|
| Trader |
|
| Importer |
Merck Sharp & Dohme (I.A.) Corporation
|
| Distributor |
|
| Application Type |
Renewal
|
| Issuance Date |
28 June 2024
|
| Expiry Date |
14 July 2029
|